Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 09/11/2022 By Sneha ShahSeptember 13, 2022
Leveraged & Inverse Channel Biotech Bounces in August as M&A Activity Increases By Ben HernandezAugust 22, 2022
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 08/07/2022 By Sneha ShahAugust 9, 2022
Leveraged & Inverse Channel Biotech Sector Is Garnering Interest From Investors Again By Ben HernandezJuly 14, 2022
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 07/10/2022 By Sneha ShahJuly 12, 2022
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 06/26/2022 By Sneha ShahJune 29, 2022
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 04/03/2022 By Sneha ShahApril 6, 2022
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 12/19/2021 By Sneha ShahDecember 21, 2021
Leveraged & Inverse Channel Omicron Variant Is Boosting This Leveraged Biotech ETF By Ben HernandezDecember 15, 2021
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 11/07/2021 By Sneha ShahNovember 9, 2021
Leveraged & Inverse Channel This Bearish Biotech ETF Is up 16% in the Past Month By Ben HernandezOctober 12, 2021
Leveraged & Inverse Channel These 3 Popular ETFs Are Geared Toward Tactical Plays By Ben HernandezApril 14, 2021
Leveraged & Inverse Channel Biden’s Infrastructure Can Put These 2 Leveraged Funds in Play By Ben HernandezApril 9, 2021
Leveraged & Inverse Channel Up Over 100% in 2020 and 15% in 2021, ‘LABU’ Isn’t Holding Back By Ben HernandezJanuary 12, 2021
Leveraged & Inverse Channel 3 Direxion ETFs Top List of Best Leveraged Performers By Ben HernandezDecember 22, 2020
Featured Stock ETFs Trade Mixed Despite Encouraging Vaccine Developments By Ian YoungNovember 18, 2020
Leveraged & Inverse Channel Short Sellers Back Off From Biotech ETFs By Ben HernandezSeptember 28, 2020
